H2-D b restricted epitopes VSV Nucleoprotein (52-59)

H2-D b restricted epitopes VSV Nucleoprotein (52-59)

• CAS Number: 132326-74-0
• UNSPSC Description: H2-D b restricted epitopes VSV Nucleoprotein (52-59) is a 9-mer peptide derived from the nucleoprotein of Vesicular Stomatitis Virus (VSV). H2-D b restricted epitopes VSV Nucleoprotein (52-59) binds to MHC class I molecules and presents itself to CD8+ T cells, thereby activating cytotoxic T lymphocytes (CTLs), which can recognize and kill cells expressing the corresponding antigen. H2-D b restricted epitopes VSV Nucleoprotein (52-59) can be used in the development of CTL vaccines against Ebola virus[1].
• Target Antigen: Others
• Type: Peptides
• Related Pathways: Others
• Applications: COVID-19-anti-virus
• Field of Research: Infection; Others
• Assay Protocol: https://www.medchemexpress.com/h2-d-b-restricted-epitopes-vsv-nucleoprotein-52-59.html
• Smiles: O=C(N[C@@H](CCC(N)=O)C(NCC(N[C@H](C(O)=O)CC(C)C)=O)=O)[C@@H](NC([C@H](C(C)C)NC([C@@H](NC(CNC([C@@H](N)CCCNC(N)=N)=O)=O)CC(C=C1)=CC=C1O)=O)=O)CC(C=C2)=CC=C2O
• Molecular Weight: 955.07
• References & Citations: [1]Herst C V, et al. An effective CTL peptide vaccine for Ebola Zaire Based on Survivors’ CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design[J]. Vaccine, 2020, 38(28): 4464-4475.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported